Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report
Inflammation and coagulation are considered to the development of Coronavirus disease 2019 (COVID-19)-related hypoxemia. However, this is still controversial, which brings challenges to clinical treatment. Here, we reviewed the levels of interleukin-6 (IL-6), coagulation indexes, and clinical manife...
Enregistré dans:
Auteurs principaux: | Xu Qiancheng, Wang Tao, Lu Weihua |
---|---|
Format: | article |
Langue: | EN |
Publié: |
De Gruyter
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b3dda005a6c1475fb8f32cbf7445c68a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
par: Wiktoria Feret, et autres
Publié: (2021) -
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
par: Zarębska-Michaluk D, et autres
Publié: (2021) -
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
par: Hayder M. Al-kuraishy, et autres
Publié: (2021) -
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
par: Rowaiye AB, et autres
Publié: (2021) -
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
par: Kavya Srinivasan, et autres
Publié: (2021)